These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36147635)

  • 1. Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma.
    Li T; Liu H; Dong C; Lyu J
    Biomed Res Int; 2022; 2022():5249576. PubMed ID: 36147635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray data analysis to identify miRNA biomarkers and construct the lncRNA-miRNA-mRNA network in lung adenocarcinoma.
    Song Y; Kelava L; Zhang L; Kiss I
    Medicine (Baltimore); 2022 Sep; 101(36):e30393. PubMed ID: 36086747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
    Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
    Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the circRNA-miRNA-mRNA Prognostic Regulatory Network in Lung Adenocarcinoma.
    Ma Y; Zou H
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma.
    Xin G; Cao X; Zhao W; Lv P; Qiu G; Li Y; Wang B; Fang B; Jia Y
    Math Biosci Eng; 2020 Nov; 17(6):8074-8083. PubMed ID: 33378933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a 7-miRNA signature for predicting the prognosis of patients with lung adenocarcinoma.
    Liu R; Guo Z; Huang J; Li J; Tan Q; Luo Q
    Exp Biol Med (Maywood); 2022 Apr; 247(8):641-657. PubMed ID: 35068222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
    Li J; Gu X; Gao C; Zhang J
    Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Three Differentially Expressed miRNAs as Potential Biomarkers for Lung Adenocarcinoma Prognosis.
    Wang W; Liu B; Duan X; Feng X; Wang T; Wang P; Ding M; Zhang Q; Feng F; Wu Y; Yao W; Wang Q; Yang Y
    Comb Chem High Throughput Screen; 2020; 23(2):148-156. PubMed ID: 31976830
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
    Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55.
    Fu L; Li Z; Wu Y; Zhu T; Ma Z; Dong L; Ding J; Zhang C; Yu G
    Biochem Genet; 2023 Aug; 61(4):1528-1547. PubMed ID: 36658310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and Validation of the Prognosis ability of the M7GRelated miRNAs in Lung Adenocarcinoma.
    Qiu X; Chen Y; Zhu X; Gong Z; Yu F; Zhang P; Song Y; Li H
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1275-1287. PubMed ID: 37116150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nine microRNAs as potential biomarkers for lung adenocarcinoma.
    Ren ZP; Hou XB; Tian XD; Guo JT; Zhang LB; Xue ZQ; Deng JQ; Zhang SW; Pan JY; Chu XY
    FEBS Open Bio; 2019 Feb; 9(2):315-327. PubMed ID: 30761256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying and Validating a Novel miRNA-mRNA Regulatory Network Associated with Prognosis in Lung Adenocarcinoma.
    Xu WQ; Ye JJ; Chen TB
    Chin Med Sci J; 2022 Mar; 37(1):31-43. PubMed ID: 35531948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
    Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
    Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments.
    Li W; Feng SS; Wu H; Deng J; Zhou WY; Jia MX; Shi Y; Ma L; Zeng XX; Zuberi Z; Fu D; Liu X; Chen Z
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.